Back to CAPTRUST FINANCIAL ADVISORS CAPTRUST FINANCIAL ADVISORS

NKTRNKTR
22 quarters

Position history for CAPTRUST FINANCIAL ADVISORSCAPTRUST FINANCIAL ADVISORS's holdings in Nektar Therapeutics

CAPTRUST FINANCIAL ADVISORS previously held 0 shares of NKTR (Nektar Therapeutics), worth $0 as of 2025-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$2,000

Total Shares Change

-60

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$25.76
0
2025-Q1
Increased
32,152
+167.9%
$21,8630.0%$11.10
30
2024-Q4
Decreased
12,001
-5.9%
$11,1610.0%$14.10
0
2024-Q3
Increased
12,748
+6.2%
$16,5720.0%$17.55
13
2024-Q2
Unchanged
12,000
0.0%
$14,8800.0%$18.60
0
2024-Q1
Decreased
12,000
-0.2%
$11,2100.0%$13.95
0
2023-Q4
Decreased
12,024
-33.8%
$6,7940.0%$8.40
0
2023-Q3
Increased
18,163
+24.5%
$10,8180.0%$9.00
14
2023-Q2
Decreased
14,585
-24.0%
$8,3890.0%$8.70
0
2023-Q1
New
19,191
-
$13,4890.0%$9.60
25
2022-Q4
Exited
0
-100.0%
$00.0%$33.90
0
2022-Q3
Increased
23,049
+600.4%
$74,0000.0%$45.60
34
2022-Q2
Increased
3,291
+12.5%
$13,0000.0%$59.40
20
2022-Q1
Increased
2,926
+51.7%
$16,0000.0%$83.55
25
2021-Q4
Increased
1,929
+15.6%
$26,0000.0%$210.00
22
2021-Q3
Increased
1,669
+3.5%
$30,0000.0%$268.95
20
2021-Q2
Decreased
1,613
-0.7%
$28,0000.0%$261.15
0
2021-Q1
Increased
1,625
+364.3%
$32,0000.0%$292.65
32
2020-Q4
Increased
350
+20.7%
$6,0000.0%$269.10
19
2020-Q3
New
290
-
$5,0000.0%$253.35
21
2019-Q3
Exited
0
-100.0%
$00.0%$268.50
0
2019-Q2
New
60
-
$2,0000.0%$533.70
15

Other major holders of NKTR: BNP PARIBAS FINANCIAL MARKETS, Invesco Ltd., PRIMECAP MANAGEMENT CO/CA/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used